CA
LLY icon

CastleArk Alternatives’s Eli Lilly LLY Stock Holding History

CastleArk Alternatives’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-175,845
Closed -$40.6M – 161
2021
Q3 		$40.6M Buy
+175,845
New +$43.4M 1.55% 16

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CastleArk Alternatives's LLY Position: Q4 2021 in Review

CastleArk Alternatives sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 175,845 shares — an estimated $40.6M sold.

CastleArk Alternatives first reported a position in LLY in Q3 2021 and held it in 1 quarter. The position peaked at $40.6M in Q3 2021. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • CastleArk Alternatives reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
  • CastleArk Alternatives sold 175,845 Eli Lilly shares in Q4 2021, an estimated $40.6M.
  • CastleArk Alternatives first reported a position in Eli Lilly in Q3 2021 and held it in 1 quarter.
  • CastleArk Alternatives's Eli Lilly position peaked at $40.6M in Q3 2021.
  • 2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.